Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Weetall

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Biorxiv : the Preprint Server for Biology|July 14, 2025
<i>MAPT</i> Splicing Modulators as a Therapeutic Strategy for TauopathiesM Catarina Silva, Hannah Lindmeier, Paolo Pigini, et al.
Molecular Cancer Therapeutics|October 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical PropertiesLiangxian Cao, Marla Weetall, Christopher Trotta, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Communications Biology|April 15, 2021
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancerGiorgia Maroni, Mahmoud A Bassal, Indira Krishnan, et al.
Nature|April 24, 2007
PTC124 targets genetic disorders caused by nonsense mutationsEllen M Welch, Elisabeth R Barton, Jin Zhuo, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Biorxiv : the Preprint Server for Biology|July 14, 2025
<i>MAPT</i> Splicing Modulators as a Therapeutic Strategy for TauopathiesM Catarina Silva, Hannah Lindmeier, Paolo Pigini, et al.
Molecular Cancer Therapeutics|October 25, 2018
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical PropertiesLiangxian Cao, Marla Weetall, Christopher Trotta, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Communications Biology|April 15, 2021
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancerGiorgia Maroni, Mahmoud A Bassal, Indira Krishnan, et al.
Nature|April 24, 2007
PTC124 targets genetic disorders caused by nonsense mutationsEllen M Welch, Elisabeth R Barton, Jin Zhuo, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 7